Potti Manish 4

4 · Ocugen, Inc. · Filed Dec 17, 2021

Form 4

Period: 2021-12-16

Director

Transactions

Exercise/Conversion
Common Stock
2021-12-16$0.51/sh+13,500$6,885→ 13,500 total
Exercise/Conversion
Common Stock
2021-12-16$1.83/sh+31,500$57,645→ 45,000 total
Exercise/Conversion
Option (Right to Buy)
2021-12-16+31,500→ 87,500 total
Exercise: $1.83Exp: 2031-01-01→ Common Stock (31,500 underlying)
Award
Option (Right to Buy)
2021-12-16+16,335→ 16,335 total
Exercise: $5.02Exp: 2031-12-16→ Common Stock (16,335 underlying)
Exercise/Conversion
Option (Right to Buy)
2021-12-16+13,500→ 19,500 total
Exercise: $0.51Exp: 2030-01-02→ Common Stock (13,500 underlying)

Holdings

Footnotes (4)

[F1]The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC.
[F2]The option vests monthly in equal installments over three years commencing on January 16, 2022, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.
[F3]The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the second day of each month through January 2, 2023, subject to the Reporting Person's continued service with the Company through each such date.
[F4]The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through January 1, 2024, subject to the Reporting Person's continued service with the Company through each such date.

Documents

1 file